Related Experiment Video
Updated: Jul 6, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Clostridium difficile-associated diarrhea: an emerging threat to pregnant women
Nadine G Rouphael1, Judith A O'Donnell, Julu Bhatnagar
1Division of Bacterial Diseases, Epidemic Intelligence Service Field Assignments Branch,Centers for Disease Control and Prevention, Atlanta, GA, USA.
Objective:
To estimate if Clostridium difficile-associated disease (CDAD) is increasing in peripartum women.
Study Design:
Peripartum CDAD was assessed through 1) passive surveillance collecting clinical and pathology data on severe cases and 2) survey among infectious disease consultants (ICDs) in the Emerging Infections Network.
Results:
Ten severe cases were collected; most had associated antibiotic use. Seven women were either admitted to the ICU or underwent colectomy. Three infants were stillborn, and 3 women died. The epidemic Clostridium difficile strain was found in 2 cases. Among 798 ICDs, 419 (52%) participated in the survey. Thirty-seven respondents (9%) recalled 55 cases, mostly in the postpartum period with 21 complications, mainly due to relapse.
Conclusion:
Severe CDAD may be increasing in peripartum women. Clinicians should have a low threshold for testing, be aware of the potential for severe outcomes, and take steps to reduce both the risk of disease and resultant complications.
Related Concept Videos
Development of the Oral Microbiota
Dysbiosis of the Gut Microbiota
Development of Human Microbiota
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Bacterial Gastroenteritis
Microbiota Modulation by Antibiotics
